Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
Cost Burden of Treatment Resistance in Patients With Depression
When a clinical staging algorithm for treatment-resistant depression was applied to administrative claims data, higher scores predicted higher future medical costs.
